Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Canepa

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Giornale Italiano Di Cardiologia (2006)|April 28, 2007
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?]Marco Canepa, Francesco Chiarella
International Journal of Cardiology|October 30, 2020
Tailoring risk prediction at the patient level: future perspectives in cardiovascular medicineStefano Benenati, Marco Canepa
Journal of the American Heart Association|November 25, 2015
From Arterial Stiffness to Heart Failure: Still a Long Way to GoMarco Canepa, Majd AlGhatrif
Circulation. Heart Failure|September 7, 2022
Evolving Epidemiology of Hypertrophic Cardiomyopathy: Shifting the Focus From Instant to Lifetime Risk AwarenessMarco Canepa, Iacopo Olivotto
Giornale Italiano Di Cardiologia (2006)|May 17, 2006
[Cardiac cell therapy: the puzzle is waiting to be solved]Marco Canepa, Domenico Coviello, Francesco Chiarella
European Heart Journal|December 1, 2018
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleaguesGiacomo Tini, Iacopo Olivotto, Marco Canepa
European Journal of Heart Failure|January 27, 2021
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium-glucose co-transporter 2 inhibitors?Marco Canepa, Pietro Ameri, Mitja Lainscak
European Heart Journal|November 6, 2024
Hypertrophic cardiomyopathy evolving management: American Heart Association/American College of Cardiology vs. European Society of Cardiology guidelinesEdoardo Bertero, Marco Canepa, Iacopo Olivotto
European Journal of Clinical Investigation|February 11, 2021
The impossible quest to make cardiac amyloidosis diagnosis easyMarco Canepa, Giacomo Tini, Fabrizio Montecucco
JACC. Heart Failure|September 1, 2018
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk ScoreMarco Canepa, Luigi Tavazzi, Aldo P Maggioni, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Giornale Italiano Di Cardiologia (2006)|April 28, 2007
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?]Marco Canepa, Francesco Chiarella
International Journal of Cardiology|October 30, 2020
Tailoring risk prediction at the patient level: future perspectives in cardiovascular medicineStefano Benenati, Marco Canepa
Journal of the American Heart Association|November 25, 2015
From Arterial Stiffness to Heart Failure: Still a Long Way to GoMarco Canepa, Majd AlGhatrif
Circulation. Heart Failure|September 7, 2022
Evolving Epidemiology of Hypertrophic Cardiomyopathy: Shifting the Focus From Instant to Lifetime Risk AwarenessMarco Canepa, Iacopo Olivotto
Giornale Italiano Di Cardiologia (2006)|May 17, 2006
[Cardiac cell therapy: the puzzle is waiting to be solved]Marco Canepa, Domenico Coviello, Francesco Chiarella
European Heart Journal|December 1, 2018
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleaguesGiacomo Tini, Iacopo Olivotto, Marco Canepa
European Journal of Heart Failure|January 27, 2021
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium-glucose co-transporter 2 inhibitors?Marco Canepa, Pietro Ameri, Mitja Lainscak
European Heart Journal|November 6, 2024
Hypertrophic cardiomyopathy evolving management: American Heart Association/American College of Cardiology vs. European Society of Cardiology guidelinesEdoardo Bertero, Marco Canepa, Iacopo Olivotto
European Journal of Clinical Investigation|February 11, 2021
The impossible quest to make cardiac amyloidosis diagnosis easyMarco Canepa, Giacomo Tini, Fabrizio Montecucco
JACC. Heart Failure|September 1, 2018
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk ScoreMarco Canepa, Luigi Tavazzi, Aldo P Maggioni, et al.
Pageof 17